Publication of List of Manufacturers Granted Licence for the Manufacture of Therapeutic Goods

Overview

The Therapeutic Goods Act 1989 was enacted to provide a regulatory framework for the control of therapeutic goods in Australia, addressing the need for ensuring the safety, quality, and efficacy of these products. This legislation was introduced to fill the gap in regulatory oversight for therapeutic goods, including medicines, medical devices, and blood products, by establishing a system for their approval, registration, and monitoring. The Act is administered by the Therapeutic Goods Administration, which is a part of the Department of Health. The policy objective of this Act is to protect public health by ensuring that therapeutic goods available in Australia are of an acceptable standard, and that they are safe, effective, and of good quality. The gazette C2019G00193, issued by the Therapeutic Goods Administration, lists manufacturers granted a licence to produce therapeutic goods. This publication is a practical implementation of the Therapeutic Goods Act 1989, ensuring that the public and industry stakeholders are informed about which entities are authorised to manufacture therapeutic goods. By providing the details of the licences granted to companies such as SUDA Pharmaceuticals Ltd, EzyMed Packing Systems Pty Ltd, and TCann Pty Ltd, the Therapeutic Goods Administration reinforces its commitment to transparency and regulatory compliance in the therapeutic goods sector.

Scope and Application

The Therapeutic Goods Act 1989 applies to the regulation of therapeutic goods in Australia, which encompasses a broad range of products including medicines, medical devices, blood and blood components, tissues, and vaccines. The Act applies to entities and individuals involved in the manufacturing, importation, supply, and advertising of therapeutic goods within the Commonwealth. The legislation ensures that therapeutic goods are of acceptable quality and meet safety and efficacy standards. The Act extends across the entire nation, applying uniformly to all states and territories. However, the Act does not cover certain goods such as cosmetics, most food products, and most complementary medicines, which fall under other regulatory frameworks. The Act's application is further defined and sometimes extended through subordinate legislation, such as regulations and standards, which provide detailed requirements for specific types of therapeutic goods or manufacturing processes. These regulations can impose additional obligations on licence holders and other regulated entities, thereby enforcing the overarching principles established by the Act.

Key Provisions

The Therapeutic Goods Act 1989 (the Act) is a comprehensive piece of legislation that governs the regulation of therapeutic goods in Australia. One of the key provisions of the Act is the requirement for manufacturers of therapeutic goods to hold a valid licence (section 38). The Act mandates that the Secretary, through the Therapeutic Goods Administration (TGA), grants licences to entities that meet the necessary standards and requirements for the manufacture of therapeutic goods. This ensures that the therapeutic goods supplied to the Australian market are safe, of high quality, and meet the necessary standards. The main operative sections of the Act relevant to this notice include section 38, which outlines the process for granting licences to manufacturers, and section 41A, which provides for the publication of the list of manufacturers granted licence. Under section 38, the Secretary must assess the application for a licence and determine whether the applicant meets the necessary standards and requirements for the manufacture of therapeutic goods. The licence granted under section 38 must specify the goods that the manufacturer is permitted to manufacture, the conditions that apply to the manufacture of those goods, and the period during which the licence is in force. The Act imposes certain obligations and requirements on the parties or entities it governs. Manufacturers of therapeutic goods must hold a valid licence to manufacture those goods, and the licence must specify the goods that the manufacturer is permitted to manufacture, the conditions that apply to the manufacture of those goods, and the period during which the licence is in force. The manufacturer must also comply with any conditions attached to the licence and ensure that the therapeutic goods they manufacture meet the necessary standards and requirements. Additionally, the manufacturer must maintain records of the manufacture of therapeutic goods and provide these records to the TGA upon request. There are various offences, penalties, or civil/criminal consequences for breach of the Act. For example, section 42 of the Act provides for the imposition of civil penalties for breaches of the Act, including the manufacture of therapeutic goods without a valid licence. The maximum penalty for an individual is $22,200, while the maximum penalty for a body corporate is $1,110,000. Additionally, section 83 of the Act provides for the imposition of criminal penalties for certain offences, including the manufacture of therapeutic goods that are unsafe or of poor quality. The maximum penalty for an individual is imprisonment for five years, while the maximum penalty for a body corporate is $5.5 million. It is important for manufacturers of therapeutic goods to comply with the requirements of the Act to avoid these penalties and consequences.